Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy

{{article.zuoZheEn}}

PDF(7289 KB)
PDF(7289 KB)
Front. Med. ›› 2023, Vol. 17 ›› Issue (4) : 699-713. DOI: 10.1007/s11684-022-0972-8
RESEARCH ARTICLE

Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2023, 17(4): 699‒713 https://doi.org/10.1007/s11684-022-0972-8

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(7289 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉